NCT07544056 2026-04-22
A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
BeBetter Med Inc
Phase 2/3 Not yet recruiting
Clinical Trials
11 trialsNCT07545122 2026-04-22
CT-202
Context Therapeutics Inc.
Phase 1 Not yet recruiting
NCT07015853 2026-04-20
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
Cedars-Sinai Medical Center
Phase 2 Not yet recruiting
NCT07527819 2026-04-14
FERTILE
Peter MacCallum Cancer Centre, Australia
Not yet recruiting
NCT07528768 2026-04-14
Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer
AntiCancer Research Jamaica
Phase 2 Not yet recruiting
NCT02802423 2026-04-13
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
BioLite, Inc.
Phase 1/2 Not yet recruiting
NCT07297667 2026-04-13
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1 Not yet recruiting
NCT07523789 2026-04-13
Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
NCT07513311 2026-04-09
RESTORE
Massachusetts General Hospital
Phase NA Not yet recruiting
NCT07509515 2026-04-03
QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.
Fudan University
Phase 2 Not yet recruiting
NCT06396754 2026-03-27
AIDOBE
Institute of Cancer Research, United Kingdom
Not yet recruiting